Update shared on 19 Nov 2025
Narrative Update on Praemium: Analyst Price Target Adjustment
Analysts have raised their price target for Praemium by approximately $0.12. They cited a modest increase in the discount rate, along with slight improvements in future profitability expectations.
What's in the News
- Praemium Limited (ASX:PPS) has been added to the S&P Global BMI Index (Key Development).
- Ms Emmalene (Emma) Stepcic has been appointed as Chief Financial Officer (CFO) of Praemium, effective 1 October 2025. Emma has extensive financial leadership experience, including roles at ASX-listed organizations and international finance firms (Key Development).
- Simon Moore, Interim CFO, will leave Praemium on 19 September 2025 after completing his contract (Key Development).
Valuation Changes
- Fair Value estimate remains unchanged at A$1.12 per share.
- Discount Rate has risen slightly from 7.84% to 7.99%.
- Revenue Growth projection stays unchanged at 9.82% per year.
- Net Profit Margin expectation remains steady at 17.60%.
- Future P/E ratio has increased slightly from 26.62x to 26.73x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.